Navigation Links
Simons Foundation grant boosts brain tumor research
Date:2/1/2008

NEW YORK, January 31, 2008 A $10 million commitment from James H. and Marilyn H. Simons through the Simons Foundation will support preclinical initiatives undertaken as part of Memorial Sloan-Ketterings new Brain Tumor Center (BTC).

Established in 2007, the BTC is designed to achieve fundamental new insights into the molecular and cellular properties that drive tumor development and growth. Investigators plan to apply that knowledge to the creation of therapies that target cancer cells and the abnormal signaling pathways needed to maintain them.

With its emphasis on carrying discoveries from the basic and translational research laboratory all the way to clinical trials, the BTC offers the potential for meaningful progress against one of the most challenging forms of cancer.

We are grateful to Jim and Marilyn Simons for their foresight and generosity in helping to get the Brain Tumor Center off to a strong start, said Harold Varmus, Memorial Sloan-Ketterings President. The work to be done through the BTC is highly complex, but absolutely essential, and we welcome the Foundations support in moving forward.

The grant from the Simons Foundation will underwrite preclinical studies of new therapies to confirm that they produce their desired effect in animal models. There currently exists no drug pipeline developed specifically for gliomas, and such preclinical work is an essential step in the design of new therapies for use in humans.

Brain cancer poses a particular challenge to treatment, in part because of the difficulties involved in getting drugs to cross the blood-brain barrier, which physically shields the brain from chemicals circulating in the body. There are also concerns about the potential side effects of drugs that do succeed in entering the brain. The highly precise treatments developed through the BTC will be designed to destroy cancer cells while sparing nearby sensitive tissues an especially important consideration in dealing wi
'/>"/>

Contact: Christine Hickey
hickey1@mskcc.org
212-639-3573
Memorial Sloan-Kettering Cancer Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. The Chrysler Foundation and Kenosha Engine Plant Donate $100,000 to New YMCA Aquatics Center
2. The UV Foundation Announces February is Vitamin D Deficiency Month
3. Michael J. Fox Foundation awards up to $3 million to industry teams
4. AMERIGROUP Foundation Announces Winners of Word About Health Contest
5. Dannemiller Memorial Education Foundation and GR MedEd, Inc. Announce Oncology Summit: From Discovery to Delivery
6. Fernandez Appointed to Blue Cross Foundation Board
7. Inspector Hector(R), National Childrens Oral Health Foundation Kick Off Events for National Childrens Dental Health Month
8. Asthma Foundation Announces 2008 Asthma Capitals, Knoxville on Top Again
9. Helios Education Foundation Invests $6.5 Million in New Partnership with TGen
10. The Highmark Foundation Awards $4 Million in Highmark Healthy High 5 Grants to Two Nonprofit Organizations
11. American Legacy Foundation Comments on New York State Department of Health Petition to the FDA to Expand Consumer Access to Over the Counter Nicotine Medications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...epresentatives from the fitness,company Burn Mach... Shriners,Hospitals for Children in Chicago last ...nique, cause; The Burn Machine donated more than $...ent to the first ever Shriners,Wheelchair Bodybui...com/cgi-bin/prnh/20081203/CLW007 ) , "We k...
(Date:12/2/2008)...ersity, The Brigham and Women,s Hospital (Boston),...has found a new drug with the potential to allevia...k. , Dr Shantha Rajaratnam from Monash Universi...gical Medicine said tasimelteon, a drug which acts...ighly effective treatment for circadian rhythm sle...
(Date:12/2/2008)... Reminder, the nation,s leading,comprehensive pat... industry,technology today at Javits Center in Ne...ng and distributing video testimonials can be used... popular platforms such as YouTube, Google,Videos...with an effective,business strategy for increasin...
(Date:12/2/2008)... enterprise software and online services veteran i...scribers of Yugma,s instant web conferencing solut...RWEB) December 2, 2008 -- Yugma , the leading web... collaborate instantly using the Internet, announc...utive Officer. , , ,Vas has more than 20 years of ...
Breaking Medicine News(10 mins):Health News:Burn Machine Speed Bag Knocks 'em Out at Shriners Wheelchair Bodybuilding Camp 2Health News:New medication brings hope of jet lag cure 2Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 2Health News:Doctors Go Viral: vSling Video Testimonial Tool Offers Doctors Access to New Channels for Acquiring Patients 3Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 2Health News:Yugma Appoints Vas Bhandarkar as Chief Executive Officer 3
...onmental Protection announced today that aerial sp...mosquito larvae in Philadelphia have been resched...oLex CG, which is not a chemical pesticide, but is...that targets mosquito and black fly larvae when ad...
...known as integrin alpha 7 (integrin 7) lead to unc...cer, report researchers at the University of Pitt...ed today in the Journal of the National Cancer Ins...a7 represents an important new target for cancer t...
...5N1 strain of bird flu has been detected among pou...n capital, officials said Wednesday. The virus w... Sungai Buloh area of Selangor state, said Kamarud...se control section at the Department of Veterinary...
...to stop feeling hungry, for researchers have devel...rmone which makes people feel full . Researchers d...aturally occurring hormone that is excreted during...he brain called MC4R. When the bodys need for food...
Other Medicine News:Health News:Rescheduled: Aerial Mosquito Treatment for Philadelphia 2Health News:A New Target for Cancer Therapy-Integrin Alpha7 Molecule 2Health News:A New Target for Cancer Therapy-Integrin Alpha7 Molecule 3Health News:A New Target for Cancer Therapy-Integrin Alpha7 Molecule 4Health News:Bird Flu Reappears in Malaysia 2
(Date:12/2/2008)..., Md., Dec. 2 Micromet, ...y developing novel, proprietary antibodies for the...diseases, today announced that it has entered into...cing Facility (CEFF) with Kingsbridge Capital Limi...of the agreement, Kingsbridge has committed to pro...
(Date:12/1/2008)...E, Dec. 1 S*BIO Pte Ltd today anno... of SB1518, a potent and orally-active JAK2 inhibi...atients with chronic idiopathic myelofibrosis (CIM...the safety and tolerability of SB1518 in patients ...ts. The Phase 1 part of the study will assess the...
(Date:12/1/2008)... MEETING, Pa., Dec. 1 G...ed that dosing of subjects has begun in study MSI-... Phase 1b study of trodusquemine (MSI-1436) in ove...novel therapeutic for the treatment of type 2 diab...rally to regulate insulin and leptin pathways thro...
(Date:11/30/2008)..., CHICAGO, Dec. 1 Old...rebral blood flow and a greater number of small bl...esented today at the annual meeting of the Radiolo... The study, conducted at the University of North ...ompare brain scans of older adults who exercise to...
Breaking Medicine Technology:Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3Newly Approved HIV Drug Shows Great Promise 1290 1Newly Approved HIV Drug Shows Great Promise 1290 2Penn researchers discover new target for preventing and treating flu 10555 1Penn researchers discover new target for preventing and treating flu 10555 2Center for Science Writings presents 3A Big Fat Lies 3A The Truth about Diet Exercise and Obesity 10553 1American College of Preventive Medicine calls on ABC to cancel Eli Stone episode 10551 1
15 mm curved blade. 8 mm straight distal tip. Serrated on top of knife. Flat handle.
Fixed smooth rod which slides on skin. Designated most popular model or size.
For use with N4096 R, N4097 R and N4098 R. 18 mm wide x 167 mm long. Ten per package. Designated most popular model or size.
30 mm button end blade. Flat handle.
Medicine Products: